Upstream Bio, Inc. (UPB) — Financial Flexibility Index
Upstream Bio, Inc. (UPB) has a Financial Flexibility Index of -1.76x as of September 2025. Free cash flow of $-22.19 Million (operating CF $-22.24 Million minus capex $47.00K) represents -2% of total liabilities ($12.61 Million). Check UPB asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Upstream Bio, Inc. Financial Flexibility Index (2022–2024)
Historical Financial Flexibility Index trend for Upstream Bio, Inc. across 3 annual periods. See UPB working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Upstream Bio, Inc. (2022–2024)
Year-by-year free cash flow to debt coverage for Upstream Bio, Inc.. For the full company profile including market capitalisation, see how much is Upstream Bio, Inc. worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.94x | $-58.66 Million | $-59.17 Million | $11.87 Million | ▼ -3044.3% |
| 2023 | -0.16x | $-37.78 Million | $-37.93 Million | $240.32 Million | ▼ -3.5% |
| 2022 | -0.15x | $-18.94 Million | $-19.02 Million | $124.63 Million | — |